Janux Therapeutics, Inc.

NASDAQ:JANX

31.81 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 430.60526.75414.662212.80319.20517.15233.70330.35551.42664.75258.40355.12935.58239.389251.62570.7697.813-0.658
Short Term Investments 594.568631.277631.631438.96324.823332.56269.586286.52275.59274.008295.893306.071339.383348.118142.57001.316
Cash and Short Term Investments 1,025.173658.031646.293651.763344.028349.712303.289316.875327.016338.76354.296361.2374.965387.507394.19570.7697.8130.658
Net Receivables 5.381012.0564.4050000.7500.500000.3750.37580
Inventory 0000-2.2-1.7-1.5000-0.3-0.1-0.2-0.0280000
Other Current Assets 3.1128.293.592.4985.2135.4836.0133.7745.4234.773.4693.3541.8542.0532.0380.2620.2490
Total Current Assets 1,033.666666.321661.939658.666349.241355.195309.302321.399332.439344.33358.065364.654377.019389.588396.60871.40616.0620.658
Non-Current Assets:
Property, Plant & Equipment, Net 24.1525.05926.01726.97827.84128.52528.94929.1329.36529.17726.2772.791.5971.3560.2150.1560.1550
Goodwill 000000000000000000
Intangible Assets 000000000000000000
Goodwill and Intangible Assets 000000000000000000
Long Term Investments 000.8160.8160.8160.8160.8160.81600.8160.8160.816339.38300000
Tax Assets 000000000000000000
Other Non-Current Assets 3.73.6392.642.5242.5092.3142.4331.6112.2061.4330.2070.337-338.1750.1400.2570-0.658
Total Non-Current Assets 27.8528.69829.47330.31831.16631.65532.19831.55731.57131.42627.33.9432.8051.4960.2150.4130.155-0.658
Total Assets 1,061.516695.019691.412688.984380.407386.85341.5352.956364.01375.756385.365368.597379.824391.084396.82371.81916.2170
Liabilities & Equity:
Current Liabilities:
Account Payables 4.0262.4621.2532.2542.4242.5051.912.0512.1592.86631.9392.4583.6130.3540.8570.4280
Short Term Debt 1.7491.6893.261.5733.0342.9242.8162.7120.76300.1760.3060.1940.4240000
Tax Payables 000000000000000000
Deferred Revenue 000.0940.9721.7053.6485.344.9355.4065.9065.3714.6495.1635.2645.0653.6461.950
Other Current Liabilities 11.68413.0226.9385.815.875.3947.8386.4168.1797.5634.4475.6214.9823.173.7862.3912.7530
Total Current Liabilities 17.45917.17311.54510.60913.03314.47117.90416.11416.50716.33512.99412.51512.79712.4719.2056.8943.1810
Non-Current Liabilities:
Long Term Debt 21.27621.74222.1922.61223.02523.43123.8224.18424.54224.09223.268000.0230000
Deferred Revenue Non-Current 0000000.3071.3942.2213.8165.28900.71.842.8234.356.050
Deferred Tax Liabilities Non-Current 000000-0.307-1.3940-3.816-5.28900-1.840000
Other Non-Current Liabilities 000-00000000000077.34621.6240
Total Non-Current Liabilities 21.27621.74222.1922.61223.02523.43124.12725.57826.76327.90828.5576.7410.71.8632.82381.69627.6740
Total Liabilities 38.73538.91533.73533.22136.05837.90242.03141.69243.2744.24341.55112.51513.49714.33412.02888.5930.8550
Equity:
Preferred Stock 0000000000000391.084396.82377.34621.6243.996
Common Stock 0.0590.0520.0520.0510.0460.0460.0420.0420.0420.0420.0420.0410.0410.0410.0410.0010.0010
Retained Earnings -237.757-217.541-189.482-183.523-168.763-157.005-145.437-127.929-110.47-94.405-77.709-60.821-47.411-33.995-23.229-17.023-14.7390
Accumulated Other Comprehensive Income/Loss 2.1637.831-1.616-0.5240.665-1.175-1.06-0.739-1.535-2.277-1.907-1.567-0.270.0240.017-00-7.944
Other Total Stockholders Equity 1,258.316865.762848.723839.759512.401507.082445.924439.89432.703428.153423.388418.429413.967410.68407.966-77.346-21.6240
Total Shareholders Equity 1,022.781656.104657.677655.763344.349348.948299.469311.264320.74331.513343.814356.082366.327376.75384.795-16.771-14.638-3.948
Total Equity 1,022.781656.104657.677655.763344.349348.948299.469311.264320.74331.513343.814356.082366.327376.75384.795-16.771-14.638-3.948
Total Liabilities & Shareholders Equity 1,061.516695.019691.412688.984380.407386.85341.5352.956364.01375.756385.365368.597379.824391.084396.82371.81916.217-3.948